Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

SCP0064

Sigma-Aldrich

cAMP Dependent PKI Peptide

≥95% (HPLC), lyophilized powder

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C85H149N31O24
Molecular Weight:
1989.29
UNSPSC Code:
12352202
NACRES:
NA.32

Product Name

cAMP Dependent Protein Kinase Inhibitor PKI-tide,

Assay

≥95% (HPLC)

form

lyophilized

composition

Peptide Content, ≥67%

storage condition

protect from light

storage temp.

−20°C

Amino Acid Sequence

Ile-Ala-Ala-Gly-Arg-Thr-Gly-Arg-Arg-Gln-Ala-Ile-His-Asp-Ile-Leu-Val-Ala-Ala

Application

IAAGRTGRRQAIHDILVAA is used as a cAMP-dependent protein kinase inhibitory peptide.

Biochem/physiol Actions

cAMP dependent protein kinase inhibitors are generally designed to target the synthesis and degradation of cAMP (cyclic adenosine monophophaphate), a second messenger.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

SCP0064-5MG:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
CI0904

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design
Taylor SS, et al.
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1784(1), 16-26 (2008)
Barbara Wienen-Schmidt et al.
ChemMedChem, 16(1), 292-300 (2020-10-09)
In lead optimization, protein crystallography is an indispensable tool to analyze drug binding. Binding modes and non-covalent interaction inventories are essential to design follow-up synthesis candidates. Two protocols are commonly applied to produce protein-ligand complexes: cocrystallization and soaking. Because of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service